The imbalance of TOMM34 expression has been discovered to be associated with the growth of many cancers, such as rectal cancer (Shimokawa et al., 2006), breast cancer (Aleskandarany et al., 2012), lung cancer (Gimenez-Xavier et al., 2017), hepatic cell carcinoma (Toraih et al., 2019; Zhang et al., 2021). This evidence concerns the gene TOMM34 and cancer.